Brought to you by 
Neurostimulation device maker Neuronetics gets $30mm in D round
03 Sep 2009
Executive Summary
First-time investor New Leaf Venture Partners led a $30mm Series D financing for Neuronetics (neuromodulation devices) and adds a board member to the company. The round, which could still bring in another $458k according to the Form D, was done by 17 investors including returning shareholders Investor Growth Capital, Quaker BioVentures, Three Arch Partners, Onset Ventures, InterWest Partners, and KBL Healthcare Ventures.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com